Oncology Nursing News®

Web Exclusives

Increased Risk for Cardiovascular Disease Among Endometrial Cancer Survivors

Increased Risk for Cardiovascular Disease Among Endometrial Cancer Survivors

BY LISA SCHULMEISTER, MN, RN, FAAN

Exploring CAR T-Cell Therapy as a Bridge to HCT in ALL

Exploring CAR T-Cell Therapy as a Bridge to HCT in ALL

BY JASON HARRIS

$FDA Approves Pembrolizumab for Treatment of Relapsed/Refractory PMBCL$

FDA Approves Pembrolizumab for Treatment of Relapsed/Refractory PMBCL

BY

FDA Approves Bevacizumab Regimen for Ovarian Cancer Treatment After Surgery

FDA Approves Bevacizumab Regimen for Ovarian Cancer Treatment After Surgery

BY JASON M. BRODERICK

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

BY KRISTIE L. KAHL

Talking About the Cost of Cancer Care With Patients

Talking About the Cost of Cancer Care With Patients

BY JAMIE ROSENBERG

FDA Approves Pembrolizumab to Treat Subgroup of Advanced Cervical Cancer

FDA Approves Pembrolizumab to Treat Subgroup of Advanced Cervical Cancer

BY

FDA Grants Venetoclax Combination Full Approval for CLL

FDA Grants Venetoclax Combination Full Approval for CLL

BY JASON M. BRODERICK

Off-the-Shelf Solution Offers Renewable, Reproducible Process of CAR T-Cell Therapy

Off-the-Shelf Solution Offers Renewable, Reproducible Process of CAR T-Cell Therapy

BY KRISTIE L. KAHL

FDA Grants Priority Review to Talazoparib for Use in BRCA+ Breast Cancer

FDA Grants Priority Review to Talazoparib for Use in BRCA+ Breast Cancer

BY JASON M. BRODERICK

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc

OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.